Arcus Biosciences is an exciting young company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology. Arcus was formed in 2015 by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is located in the San Francisco bay area, in the heart of the world's largest biotechnology research hub.
Unlike many other organizations, we view the drug discovery process as one that requires equal parts of technology and art, science and elegance, not as a commodity that can be outsourced. For this reason, we have assembled and are continuing to build an internal team of uniquely qualified individuals with extraordinary knowledge, skills and drive.
Arcus is rapidly establishing a portfolio of novel therapeutics encompassing both small molecules and biologics that target various facets of the immune system implicated in pathology or modulation of the cellular processes of cancer. These new drugs will then be deployed in various combinations to combat cancer.
We are growing very actively and are always interested in hearing from scientists with a recent PhD in Chemistry, Immunology and one of the quantitative life sciences (Biochemistry, Enzymology, Molecular Pharmacology, etc). We also have openings for experienced researchers with ten or more years assay development experience applied either in the context of SAR support or clinical PD marker assays.
If this describes you, please check out the opportunities on our website at www.arcusbio.com